Doctronic is here to guide you through a personalized health journey that's faster, smarter, and more personal
It ameliorates cardiac function in type 1 diabetes by inhibiting ferroptosis via the SIRT1-p53-SLC7A11/GPX4 pathway
Cell metabolism experiments revealed an MTP-dependent ability of GLP-1(2836) to shift substrate utilization away from FAO to more efficient glucose oxidation and higher levels of cAMP
A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, Semaglutide, compared with placebo and open-label Liraglutide in patients with type 2 diabetes
Case Study 1: Bitter Melon for Type 2 Diabetes Management Background: A 55-year-old male with type 2 diabetes had difficulty managing his blood sugar levels despite medication
The goal is a productive on cycle followed by a restorative off cycle